ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.99
0.00%
US Tech 100
19,886.80
0.02%
S&P 500
5,849.72
-1.76%
US Dollar vs CAD
1.44254
-0.47%
Bitcoin
83,947.08
-2.49%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Castle Biosciences Inc (CSTL)

  7. Castle Biosciences Inc (CSTL) News

CSTL

Castle Biosciences (CSTL)

Castle Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CSTL
DateTimeSourceHeadlineSymbolCompany
02/27/20253:13PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CSTLCastle Biosciences Inc
02/27/20253:07PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CSTLCastle Biosciences Inc
02/27/20253:05PMBusiness WireCastle Biosciences Reports Fourth Quarter and Full-Year 2024 ResultsNASDAQ:CSTLCastle Biosciences Inc
02/25/20253:30PMBusiness WireCastle Biosciences to Participate in Upcoming Investor ConferencesNASDAQ:CSTLCastle Biosciences Inc
02/24/20253:23PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
02/12/20253:30PMBusiness WireCastle Biosciences to Share Data Reinforcing the Clinical Value of Its Dermatologic Portfolio of Gene Expression Profile Tests at the 22nd Annual Winter Clinical Dermatology Conference - Hawaii®NASDAQ:CSTLCastle Biosciences Inc
02/06/20256:00AMBusiness WireCastle Biosciences to Release Fourth Quarter and Full-Year 2024 Financial Results and Host Conference Call on Thursday, Feb. 27, 2025NASDAQ:CSTLCastle Biosciences Inc
01/17/20256:00AMBusiness WireCastle’s Poster on DecisionDx®-SCC Selected as a “Late Breakers” Top Five Finalist for the Akamai Award, Recognizing the Best Posters at Maui Derm Hawaii 2025NASDAQ:CSTLCastle Biosciences Inc
01/12/20255:00PMBusiness WireCastle Biosciences Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 ResultsNASDAQ:CSTLCastle Biosciences Inc
01/08/20255:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
01/06/20253:29PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CSTLCastle Biosciences Inc
01/06/20256:00AMBusiness WireCastle Biosciences Announces New York State Department of Health Approval of Its TissueCypher® Barrett’s Esophagus TestNASDAQ:CSTLCastle Biosciences Inc
12/23/20246:00AMBusiness WireCastle Biosciences Highlights Progress for its Pipeline Atopic Dermatitis Gene Expression Profile TestNASDAQ:CSTLCastle Biosciences Inc
12/19/20246:00AMBusiness WireCastle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CSTLCastle Biosciences Inc
12/12/20246:00AMBusiness WireIndependent Systematic Review and Meta-Analysis Attests to the Significant Risk Stratification Provided by Castle Biosciences’ DecisionDx®-Melanoma Test, Contributing to Personalized Management of Patients with MelanomaNASDAQ:CSTLCastle Biosciences Inc
12/11/20243:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
12/11/20243:51PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
12/11/20243:49PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
11/20/20246:00AMBusiness WireCastle Biosciences to Present at the Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:CSTLCastle Biosciences Inc
11/19/20243:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
11/19/20246:00AMBusiness WireCastle Biosciences Earns a Houston Chronicle Top Workplaces Award for the Fourth Consecutive YearNASDAQ:CSTLCastle Biosciences Inc
11/14/202412:39PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CSTLCastle Biosciences Inc
11/08/20246:00AMBusiness WireCastle Biosciences to Present New Data Highlighting the Clinical Performance of DecisionDx®-Melanoma and MyPath® Melanoma at the American Society of Dermatopathology 61st Annual MeetingNASDAQ:CSTLCastle Biosciences Inc
11/07/20243:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
11/07/20246:00AMBusiness WireCastle Biosciences Surpasses 25,000 Test Reports Delivered for its TissueCypher® Barrett’s Esophagus TestNASDAQ:CSTLCastle Biosciences Inc
11/06/20246:00AMBusiness WireUse of Castle Biosciences’ DecisionDx®-Melanoma Test Significantly Reduces Unnecessary SLNB Procedures, Latest Findings from Prospective, Multicenter DECIDE Study Presented at Dermato-Onco2024NASDAQ:CSTLCastle Biosciences Inc
11/05/20243:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
11/04/20243:11PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CSTLCastle Biosciences Inc
11/04/20243:07PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CSTLCastle Biosciences Inc
11/04/20243:05PMBusiness WireCastle Biosciences Reports Third Quarter 2024 ResultsNASDAQ:CSTLCastle Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:CSTL

Your Recent History

LSE
0RP7
Ayco Grupo Inmobiliario
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads